弱視治療機器の世界市場-2022-2029

市場力学

世界の障害や失明の増加により、市場の成長が促進されます。

ヘルスケア機器およびテクノロジーへの支出の増加が市場の成長を促進します。また、世界中で障害や失明が増加していることも、予測期間中の市場の成長を後押しします。例えば：世界保健機関2021年によると、世界中で少なくとも22億人が視力障害または失明を患っており、そのうち少なくとも10億人が予防できたはずの視力障害またはまだ対処されていない視力障害を患っていることが分かっています。失明は、未対策の屈折異常（8,840万人）、白内障（9,400万人）、緑内障（770万人）、角膜混濁（420万人）、糖尿病網膜症（390万人）、トラコーマ（200万人）、および未対策の老眼による近見障害（8.26億人）が原因とされています。また、世界中の小児・青少年の眼科疾患の治療に関する政府の積極的な取り組みが、今後一定期間の市場成長にとって有利な機会を生み出すと期待されます。

しかし、熟練した労働力の不足が市場の成長を妨げています。弱視の効果的な治療法として、閉塞療法とアトロピンについて、重要なエビデンスが得られています。しかし、弱視の診断は依然として難しく、その主な原因は、閉塞療法やアトロピンペナルティ中のコンプライアンスの問題や最適でないケア結果です。高度な技術に熟練した専門家が必要なこと、弱視治療に関する知識が不足していること、新しい専門家の育成に膨大な費用がかかることなどが、市場の成長を制限しています。

地理的浸透。

アジア太平洋地域は、予測期間中に支配的な地域です。

本調査では、地域別に、北米、欧州、アジア太平洋、南米、中東・アフリカを含む世界の弱視治療機器市場を分析しています。

アジア太平洋地域は、ヘルスケア支出の増加や技術の進歩により、世界的に市場シェアが高く、主要な地域となっています。また、同地域は2020-2026年の予測期間において、最も高い成長率/CAGRを示すと予想されています。弱視に苦しむ子供の人口増加などの要因は、アジア太平洋地域全体のカスタマイズ医療弱視治療装置市場に有利な成長の見通しを生み出します。さらに、中東・アフリカと南米も、予測期間中に健全なCAGRで成長すると予想されます。

北米と欧州は、世界市場で大きなシェアを占めると推定されます。これらの地域では、眼科病院の需要が増加しており、視力回復センターの数も増加しています。

競合情勢

弱視治療機器市場は、米国、中国、インドなどの主要地域の主要な市場プレーヤーがいるため、適度な競争状態にあります。世界市場の成長に貢献している市場プレイヤーには、広州紡績、広州石家、西安華雅、深センElmmediCare、広州石正、西安Aile、中科恒通、北京Tongmingなどが含まれます。大手企業は、弱視治療機器市場の世界の成長のために、新製品の投入や拡大戦略を採用しています。2022年1月、ヘルスケア技術の世界的リーダーであるMedtronicは、ボストン地域に拠点を置く非公開の医療技術企業であるAffera, Incを買収する正式契約を締結しています。この買収は、最も急成長している医療技術市場の1つであるマッピングとナビゲーションへの初参入を含むメドトロニックの心臓アブレーションポートフォリオの拡大に貢献します。2021年10月、FDAは、ルミノピアの怠け眼の子供の視力を向上させるデジタル治療薬を承認しました。処方箋療法としてのLuminopia Oneは、4歳から7歳の弱視で、異方性または軽度の斜視を伴う子供の視力強化に適応されます。

COVID-19の影響弱視治療機器の世界市場にネガティブな影響を与えます。

COVID-19の世界の負担により、医療用弱視治療機器の需要は急速に拡大すると予測されます。パンデミックの結果、医療用弱視治療機器業界のサプライヤーは、新しい政府の規制を遵守するために事業活動の中断を余儀なくされました。この慣らし運転は、世界の医療用弱視治療機器業界の販売フローに大きな影響を与えます。

世界の弱視治療機器市場レポートでは、約56の市場データ表、41の図、170ページの構成で提供しています

目次

第1章 調査手法と調査範囲

• 調査手法
• 調査目的および調査範囲

第2章 市場の定義と概要

第3章 エグゼクティブサマリー

• 製品別市場内訳
• アプリケーション別市場内訳
• 地域別市場内訳

第4章 弱視治療機器市場-市場力学

• 市場影響要因
  • 促進要因
    • ヘルスケア支出の増加が弱視治療機器市場の成長を後押し。
    • eコマース業界からの需要増
  • 抑制要因
    • 熟練労働者の不足
  • 影響分析

第5章 産業分析

• ポーターのファイブフォース分析
• サプライチェーン分析
• バリューチェーン分析
• PEST分析
• プライシング分析
• 法規制分析
• 保険償還分析
• アンメットニーズ
• 特許動向

第6章 COVID-19の分析

• COVID-19の市場分析
  • COVID-19以前の市場シナリオ
  • COVID-19の現在の市場シナリオ
  • COVID-19の後、あるいは将来のシナリオ
• COVID-19の中での価格ダイナミクス
• 需要-供給スペクトラム
• パンデミック時の市場に関連する政府の取り組み
• メーカーの戦略的な取り組み
• まとめ

第7章 製品別

• カラー/アイコン装置
• 総合装置

第8章 アプリケーション別

• 眼科病院
• 視力回復センター

第9章 地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • その他欧州
• 南米
  • ブラジル
  • アルゼンチン
  • その他の南米地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • オーストラリア
  • その他アジア太平洋地域
• 中東・アフリカ地域

第10章 競合情勢

• 競合シナリオ
• 市況ポジショニング／シェア分析
• M&A（合併・買収）分析

第11章 弱視治療機器市場-企業プロファイル

• Guangzhou Boshi
  • 企業概要
  • 製品ポートフォリオと説明
  • 主なハイライト
  • 財務概要
• Medtronic
• Microlife
• Guangzhou Shijia
• Omron
• Xi'an Huaya
• Shenzhen ElmmediCare
• Guangzhou Shizheng
• Xi'an Aile
• Zhongke Hengtong
• Beijing Tongming（List Not Exhaustive）

第12章 重要考察

第13章 DataM

Market Overview

Amblyopia Therapeutic Apparatus Market was valued at USD XX million in 2021. It is forecasted to reach USD XX million by 2029, growing at a CAGR of 2.9 % during the forecast period (2022-2029).

Amblyopia therapeutic apparatus is a device used to treat Amblyopia, often referred to as "lazy eye" Amblyopia is reduced vision in one or both eyes owing to abnormal vision production in infancy or childhood. There might not be an apparent issue with the eye in Amblyopia. Vision deficiency happens when the nerve impulses between the brain and the retina are not adequately activated. The brain "learns" to see only fuzzy images of an amblyopia eye, even though glasses are used. Consequently, one eye is favored by the brain, usually due to impaired vision with the other eye. Amblyopia therapeutic apparatus is widely used in homecare, hospitals and ophthalmologic centers. The growth of the amblyopia therapeutic apparatus market is the growing demand for amblyopia therapeutic apparatus due to rising healthcare expenditure and favorable government regulations.

Market Dynamics: The increasing prevalence of impairments or blindness incidence across the globe is driving the market's growth.

Growth in expenditure incurred on healthcare equipment and technology will propel the market's growth. Besides, the increasing prevalence of impairments or blindness across the globe drives the market's growth over the forecast years. For instance: as per World Health Organization 2021, at least 2.2 billion people worldwide have a vision impairment or blindness, of whom at least 1 billion have a vision impairment that could have been prevented or has yet to be addressed. Blindness is due to unaddressed refractive error (88.4 million), cataract (94 million), glaucoma (7.7 million), corneal opacities (4.2 million), diabetic retinopathy (3.9 million), and trachoma (2 million), as well as near vision impairment caused by unaddressed presbyopia (826 million). Also, the favorable government initiatives taken regarding treating several eye diseases in the Children or Adolescents population across the globe are expected to create a lucrative opportunity for the market's growth over the forthcoming period.

However, the lack of a skilled workforce hampers market growth. Significant evidence has emerged for effective treatment of amblyopia, occlusion therapy and atropine. However, amblyopia diagnosis remains difficult, primarily due to compliance problems and sub-optimal care results during occlusion and atropine penalization. The requirement of skilled professionals for advanced technology, lack of knowledge about amblyopia therapeutic and huge costs incurred in training new professionals limit the market growth.

Market Segmentation: The color/Icon apparatus segment is projected to be the market's dominant segment during the forecast period.

Based on the product, the amblyopia therapeutic apparatus market has been classified into Color/Icon apparatus and comprehensive apparatus.

Color/Icon apparatus dominated the global market in 2021, whereas the organic amblyopia therapeutic apparatus is expected to present considerable growth shortly. Color/icon amblyopia therapeutic apparatus is much more appropriate for getting rid of amblyopia. Therefore, the increasing usage of color/Icon Apparatuses in the amblyopia therapeutic apparatus is expected to propel the near future segmental growth.

Amblyopia therapeutic apparatus is segmented based on application, which includes an eye hospital and vision recovery center.

Eye hospital segment held significant market share in global amblyopia therapeutic apparatus market. Most of this amblyopia therapeutic involves the diagnosis and treatment care of the patients for various amblyopia. These services are provided through public or private eye hospitals and clinics. The countries are developing their public and private hospitals to provide better medical treatments to the population. Moreover, the increasing number of overall treatments in hospitals includes procedures including Glasses and eye patches, further driving the market growth. According to the American Academy of Ophthalmology report published in 2021, According to the United States Census Bureau stated, the population of the United States is 289 million; among this, 151 million people require some form of vision correction, and 24% of the population (69 million people) is myopic, and it is estimated that about 43 million of these are candidates for refractive surgery. 60% have less than 2 diopters (D) of myopia, 39% have 2 to 8 D of myopia, and fewer than 1% have more than 8 D of myopia. Approximately 26% of the United States population (75 million people) are hyperopic, but only 15 million of these are candidates for refractive surgery. The average age of refractive surgery patients with myopia is 40 years, and with hyperopia, 55 years.

Geographical Penetration: Asia Pacific is the dominating region during the forecast period.

Based on geography, the study analyzes the amblyopia therapeutic apparatus market globally, including North America, Europe, Asia-Pacific, South America, and the Middle East & Africa.

The Asia Pacific is the leading/significant region globally in terms of market share due to the increasing growth in healthcare expenditure and technological advancement. In comparison, the region is also anticipated to exhibit the highest growth rate / CAGR over the forecast period 2020-2026. Factors such as the rising population of children suffering from amblyopia would create lucrative growth prospects for the customized medical amblyopia therapeutic apparatus market across the Asia-Pacific region. Moreover, the Middle East & Africa and South America are also expected to grow with a healthy CAGR over the forecast period.

North America and Europe are estimated to hold a significant share in the global market. Increasing demand in eye hospitals across these regions also increases the number of vision recovery centers.

Competitive Landscape:

The amblyopia therapeutic apparatus market is moderately competitive, due to major market players in the key regions such as the US, China, India and others. Market players contributing to the growth of the global market include Guangzhou Boshi, Guangzhou Shijia, Xi'an Huaya, Shenzhen ElmmediCare, Guangzhou Shizheng, Xi'an Aile, Zhongke Hengtong, Beijing Tongming, among others. The major players are adopting new product launches and expansion strategies for global growth in the Amblyopia Therapeutic Apparatus market. In January 2022, Medtronic, a global leader in healthcare technology, has a definitive agreement to acquire Affera, Inc, a Boston area-based, privately held medical technology company. This acquisition helps to expand Medtronic's cardiac ablation portfolio, including first-time entry into mapping and navigation, within one of the fastest-growing MedTech markets. In October 2021, FDA approved Luminopia's digital therapeutic to enhance vision in children with lazy eyes. Luminopia One as a prescription therapy is indicated for enhancement in visual acuity in children with amblyopia aged between four and seven years and associated with anisometropia or mild strabismus.

COVID-19 Impact: Negative impact on the global amblyopia therapeutic apparatus market.

The demand for medical amblyopia therapeutic equipment is projected to expand rapidly due to the global burden of COVID-19. As a result of the pandemic, suppliers of the Medical Amblyopia Therapeutic Apparatus industry were forced to suspend their business operations to comply with the new government regulations. This break-in operation significantly affects the sales flow in the global industry for medical amblyopia.

The global amblyopia therapeutic apparatus market report would provide an access to approximately 56 market data tables, 41 figures and 170 pages

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

• 3.1. Market Snippet by Product
• 3.2. Market Snippet by Application
• 3.3. Market Snippet by Region

4. Amblyopia Therapeutic Apparatus Market-Market Dynamics

• 4.1. Market Impacting Factors
  • 4.1.1. Drivers
    • 4.1.1.1. Increasing HealthCare Expenditure boosts the market growth for Amblyopia Therapeutic Apparatus.
    • 4.1.1.2. Increasing demand from the e-commerce industry
  • 4.1.2. Restraints:
    • 4.1.2.1. Lack of skilled workforce
  • 4.1.3. Impact Analysis

5. Industry Analysis

• 5.1. Porter's Five Forces Analysis
• 5.2. Supply Chain Analysis
• 5.3. Value Chain Analysis
• 5.4. PEST Analysis
• 5.5. Pricing Analysis
• 5.6. Regulatory Analysis
• 5.7. Reimbursement Analysis
• 5.8. Unmet Needs
• 5.9. Patent Trends

6. COVID-19 Analysis

• 6.1. Analysis of Covid-19 on the Market
  • 6.1.1. Before COVID-19 Market Scenario
  • 6.1.2. Present COVID-19 Market Scenario
  • 6.1.3. After COVID-19 or Future Scenario
• 6.2. Pricing Dynamics Amid Covid-19
• 6.3. Demand-Supply Spectrum
• 6.4. Government Initiatives Related to the Market During Pandemic
• 6.5. Manufacturers Strategic Initiatives
• 6.6. Conclusion

7. By Product

• 7.1. Introduction
• 7.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Segment
• 7.3. Market Attractiveness Index, By Product Segment
  • 7.3.1. Color/Icon Apparatus
    • 7.3.1.1. Introduction
    • 7.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
  • 7.3.2. Comprehensive Apparatus

8. By Application

• 8.1. Introduction
• 8.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application Segment
• 8.3. Market Attractiveness Index, By Application Segment
  • 8.3.1. Eye Hospital
    • 8.3.1.1. Introduction
    • 8.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
  • 8.3.2. Vision Recovery Centre

9. By Region

• 9.1. Introduction
• 9.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
• 9.3. Market Attractiveness Index, By Region
• 9.4. North America
  • 9.4.1. Introduction
  • 9.4.2. Key Region-Specific Dynamics
  • 9.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
  • 9.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  • 9.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    • 9.4.5.1. The U.S.
    • 9.4.5.2. Canada
    • 9.4.5.3. Mexico
• 9.5. Europe
  • 9.5.1. Introduction
  • 9.5.2. Key Region-Specific Dynamics
  • 9.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
  • 9.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  • 9.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    • 9.5.5.1. Germany
    • 9.5.5.2. The U.K.
    • 9.5.5.3. France
    • 9.5.5.4. Italy
    • 9.5.5.5. Spain
    • 9.5.5.6. Rest of Europe
• 9.6. South America
  • 9.6.1. Introduction
  • 9.6.2. Key Region-Specific Dynamics
  • 9.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
  • 9.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  • 9.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    • 9.6.5.1. Brazil
    • 9.6.5.2. Argentina
    • 9.6.5.3. Rest of South America
• 9.7. Asia Pacific
  • 9.7.1. Introduction
  • 9.7.2. Key Region-Specific Dynamics
  • 9.7.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
  • 9.7.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  • 9.7.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    • 9.7.5.1. China
    • 9.7.5.2. India
    • 9.7.5.3. Japan
    • 9.7.5.4. Australia
    • 9.7.5.5. Rest of Asia Pacific
• 9.8. The Middle East and Africa
  • 9.8.1. Introduction
  • 9.8.2. Key Region-Specific Dynamics
  • 9.8.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
  • 9.8.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  • 9.8.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

10. Competitive Landscape

• 10.1. Competitive Scenario
• 10.2. Market Positioning/Share Analysis
• 10.3. Mergers and Acquisitions Analysis

11. Amblyopia Therapeutic Apparatus Market- Company Profiles

• 11.1. Guangzhou Boshi
  • 11.1.1. Company Overview
  • 11.1.2. Product Portfolio and Description
  • 11.1.3. Key Highlights
  • 11.1.4. Financial Overview
• 11.2. Medtronic
• 11.3. Microlife
• 11.4. Guangzhou Shijia
• 11.5. Omron
• 11.6. Xi'an Huaya
• 11.7. Shenzhen ElmmediCare
• 11.8. Guangzhou Shizheng
• 11.9. Xi'an Aile
• 11.10. Zhongke Hengtong
• 11.11. Beijing Tongming (List Not Exhaustive)

12. Premium Insights

13. DataM Intelligence

• 13.1. Appendix
• 13.2. About Us and Services
• 13.3. Contact Us